Mithramycin prodrug nanoformulations for improved disease treatment
This technology introduces a novel nano-formulation of Mithramycin A designed to improve cancer treatment effectiveness while significantly reducing associated liver toxicity.
Background:
Mithramycin A (MithA) is a potent inhibitor of RNA synthesis that binds to DNA and has demonstrated effectiveness against a specific oncogene found in Ewing sarcoma,...
Published: 6/21/2026
|
Inventor(s): Juntao Luo, Jason Horton, Dandan Guo, Mei Yun Lin
Keywords(s): cancer therapy, nanomedicine, targeted drug delivery, Technologies
Category(s): Campus > Upstate Medical University, Technology Classifications > Drug Design and Synthesis
|